India to Australia: Irinotecan Export Trade Route

The India to Australia Irinotecan corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $1.1M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 62% of all export value, reflecting the consolidated nature of India's irinotecan manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $114.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with irinotecan's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 12.5%, placing it at rank #14 among India's top irinotecan export destinations globally.

On the import side, key buyers of Indian irinotecan in Australia include ACCORD HEALTHCARE PTY LTD, ACCORD HEALTHCARE PTY LTD , TO THE ORDER and 2 others. ACCORD HEALTHCARE PTY LTD is the single largest importer with 5 shipments valued at $544.2K USD.

India's irinotecan exports to Australia are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD — together account for 93% of total trade value on this route. The average shipment value of $114.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ph dru med irinotecan accord20mg ml 25ml1v pp ac au each ml contains irinotecan hydrochloride trihydrate 20mg and phar.drugs and med.: irinotecan accord20mg/ml25ml1v pp (ac-au each ml contains:irinotecan hydrochloride trihydrate 20vls, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE PTY LTD is the largest importer with 5 shipments worth $544.2K USD — representing 48% of all irinotecan imports from India on this route.